ACXP•benzinga•
Why Acurx Pharmaceuticals (ACXP) Shares Are Down 30%
Summary
Acurx Pharmaceuticals shares are trading lower by 30% during Friday's session. The company announced a $1.1 million registered direct offering.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 7, 2025 by benzinga